21 related articles for article (PubMed ID: 17475345)
1. Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity.
DiPatrizio NV
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916974
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB
Avalos B; Argueta DA; Perez PA; Wiley M; Wood C; DiPatrizio NV
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32962222
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences.
Higuchi S; Irie K; Yamaguchi R; Katsuki M; Araki M; Ohji M; Hayakawa K; Mishima S; Akitake Y; Matsuyama K; Mishima K; Mishima K; Iwasaki K; Fujiwara M
PLoS One; 2012; 7(6):e38609. PubMed ID: 22737214
[TBL] [Abstract][Full Text] [Related]
4. Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
Shin AC; Pistell PJ; Phifer CB; Berthoud HR
Neuroscience; 2010 Oct; 170(2):580-8. PubMed ID: 20654704
[TBL] [Abstract][Full Text] [Related]
5. Preference or fat? Revisiting opioid effects on food intake.
Taha SA
Physiol Behav; 2010 Jul; 100(5):429-37. PubMed ID: 20211638
[TBL] [Abstract][Full Text] [Related]
6. Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.
Lenard NR; Zheng H; Berthoud HR
Int J Obes (Lond); 2010 Jun; 34(6):1001-10. PubMed ID: 20065959
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
8. AM 251 and beta-Funaltrexamine reduce fat intake in a fat-preferring strain of mouse.
South T; Deng C; Huang XF
Behav Brain Res; 2007 Jul; 181(1):153-7. PubMed ID: 17475345
[TBL] [Abstract][Full Text] [Related]
9. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
Mathes CM; Ferrara M; Rowland NE
Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
[TBL] [Abstract][Full Text] [Related]
10. The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice.
Sakamoto K; Okahashi T; Matsumura S; Okafuji Y; Adachi S; Tsuzuki S; Inoue K; Fushiki T
Biosci Biotechnol Biochem; 2015; 79(4):658-63. PubMed ID: 25516200
[TBL] [Abstract][Full Text] [Related]
11. The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance.
Sakamoto K; Matsumura S; Okafuji Y; Eguchi A; Yoneda T; Mizushige T; Tsuzuki S; Inoue K; Fushiki T
Physiol Behav; 2015 Jan; 138():227-35. PubMed ID: 25446206
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.
Chen RZ; Huang RR; Shen CP; MacNeil DJ; Fong TM
Brain Res; 2004 Mar; 999(2):227-30. PubMed ID: 14759503
[TBL] [Abstract][Full Text] [Related]
13. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
